BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Laser capture microdissection
,
Trichostatin A
,
rs2230926
,
PRKCA
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
End3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Effects of heat
Deficiency state
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Thorium
Benzoates
5-hydroxymethylfurfural
Furaldehyde
6-nonadecynoic acid
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
mst1
isp7
RAD61
BAS1
SPT10
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeted disruption of an EH-domain protein endocytic complex, Pan1-End3.
Gene co-expression network analysis reveals the positive impact of endocytosis and mitochondria-rela…
The tandem EH domains of End3 cooperate to interact with dual XPF motifs of Sla1 for the connection …
The Plasma Membrane Protein Nce102 Implicated in Eisosome Formation Rescues a Heme Defect in Mitocho…
Candida albicans END3 Mediates Endocytosis and Has Subsequent Roles in Cell Wall Integrity, Morpholo…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for End3
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ